Localized promoter hypermethylation and overall DNA hypomethylation have been associated with the presence of tumor in humans. Yet, despite the large amount of recently produced epigenetic data, there is still a lack of understanding on how several genes behave in tumor cells with respect to their epigenetic alterations such as DNA methylation. Here we performed a novel type of analysis that measures the correlation of DNA methylation levels between two genes across many samples. We linked this so-called co-methylation to the genomic distance of these genes, their functional similarity and their expression levels. Co-methylation analysis of more than 300 breast cancer samples from the TCGA portal yielded 187 pairs of genes showing Pearson correlation coefficients |r| ≥ ≥ 0.75. These pairs were formed by 133 genes. Less than half of these pairs are located on the same chromosome. For these, we found that the level of co-methylation is weakly anti-correlated with genomic distance (r 5 20.29). Linking co-methylation with the functional similarity of genes showed that genes with r ≥ 0.8 tend to have similar molecular function and to be involved in the same biological process as described in the Gene Ontology project. Clustering of highly co-methylated genes identified four enriched KEGG pathways. Hence we have introduced co-methylation as a new indicator to discover functional associations between gene pairs in breast cancer and furthermore to discover new candidate genes that should be inspected more closely in the context of the studied disease.
INTRODUCTION
Besides all the large or small genetic variations that have been linked to many human diseases so far, we are just about to start appreciating the large amount of variability with respect to epigenetic variations in humans and between disease and healthy samples. Clearly, the epigenome is different and it impacts gene expression (1) . Although epigenetic information is not encoded in genes, the information encoded by DNA can be directly affected by epigenetic modification such as DNA methylation (2) . About 1% of all human DNA base pairs consist of methylated cytosine bases, where a methyl group is covalently attached to the C5 position of cytosine (3) . Since most of these are found in conjunction with CpG dinucleotides, 60-90% of all CpGs are methylated in human (4) . Furthermore, DNA methylation is associated with parasitic DNA suppression (5), repression of gene transcription (6) and genomic imprinting (7) . In addition to that, DNA methylation plays an important role in cancer where the genome is mostly hypomethylated except for promoter regions of tumor-suppressor genes that are conversely hypermethylated (8 -10) .
In this analysis, we focused on breast cancer, a genetically heterogeneous type of cancer that belongs to the most prevalent and best studied types (11) . The OMIM database contains 22 genes, mutations of which are associated with this cancer type (Online Mendelian Inheritance in Man, OMIMw; John Hopkins University, Baltimore, MD, USA; MIM number: 114480; worldwide web URL: http://omim.org). Among these, the important BRCA1 gene was shown to exhibit cancerspecific methylation patterns (12) as well as a number of other genes such as RASSF1, ARHGDIB, GRB7, SEMA3B, MMP7, PEG10, GSTP1, CHI3L2 (13) . Thus, there exists ample evidence that altered DNA methylation is associated with the development of breast cancer (14, 15 Since huge amounts of epigenetic data are nowadays being generated thanks to modern technologies such as ChIP-on-chip, ChIP-seq and bisulfite sequencing, the new field of computational epigenetics aims to analyze these data and to link them to functional data (16) . A number of international projects like TCGA, BLUEPRINT, DEEP, AHEAD, ENCODE, HEP and IHEC initiated human epigenome sequencing and mapping. A recent study reported the association of the promoter methylation profile of P14 ARF , MDM2, TP53 and PTEN genes with regulatory pathways of the tumorsuppressor gene TP53 (17) . In general, functional similarity or participation in a common pathway is known to lead to gene co-expression (18) (19) (20) . This motivated us to investigate in an analogous way the possibility of co-methylation of genes across samples. Figure 1 illustrates the main idea behind this study.
We based our analysis on breast cancer samples from the TCGA initiative that collects and analyzes tumor and nontumor samples and makes it available to the public through their data portal. We analyzed possible relations between DNA co-methylation and genomic distance, functional similarity or pathway enrichment, respectively.
RESULTS

Co-methylation
First, we investigated the degree of correlation of the relative methylation levels in between any two genes in breast cancer samples. Pearson correlation coefficients for DNA methylation were computed for 88 611 328 unique pairs of genes that are retained after preprocessing of the raw data as described in the Materials and Methods section. Co-methylation analysis of 344 samples deposited in September and October 2011 (including 317 tumor samples and 27 matched tissue mostly from adjacent health tissues) yielded 377 547 pairs of genes with |r| ≥ 0.75 and 13 643 pairs with |r| ≥ 0.9. The absolute frequencies of different levels of co-methylation for the actual data and for randomly permutated data, used as contrast set, are shown in Figure 2 . The co-methylation plot for randomized data on a logarithmic scale shows that 99.9% of all gene pairs possess an absolute correlation of ,0.2. In contrast, 25.41% of the gene pairs show correlation coefficients .0.2 for real data. We see this as a strong indication of our working hypothesis.
During data processing, we noticed that high correlation levels may sometimes be caused by one single or a few outlying data points or may arise between genes that show very little variation in their methylation levels. Therefore, we removed all pairs of genes where one or both genes contained 'outliers' in one or more samples (see Materials and Methods) and we ensured that all genes showed a certain variation of their CpG methylation levels. After removing such co-methylated pairs of genes, 187 highly correlated pairs remained (|r| ≥ 0.75), involving 133 different genes. These gene pairs are listed in Supplementary Material, Table S1 . Supplementary Material, Figure S3 shows a hierarchical agglomerative clustering dendrogram of these genes based on the Euclidian distance of their b-values. In contrast, the data set of 344 randomly permutated TCGA samples did not contain any highly correlated gene pairs after this filtering step. Already prior to this, only 91 pairs of genes were above the threshold of |r| ≥ 0.75. Thus, the chance of finding highly correlated methylation levels for pairs of genes in randomly shuffled data is therefore 91 out of 377 547 ¼ 2.41 . e -4. This value is therefore the P-value for identifying highly correlated methylation levels for gene pairs in breast cancer samples.
Genomic distance
In bacterial operons, neighboring genes are often expressed together. Similar to this is the phenomenon of genomic imprinting where few imprinting control regions affect the allele-specific methylation in their genomic environment. Thus, one may expect that also methylation of neighboring genes could be higher correlated than that of distant genes. Here, we investigated whether genes showing a high correlation of their DNA methylation levels tend to be located closely to each other on chromosomes. Among the 187 pairs of genes that passed the threshold of |r| ≥ 0.75, 74 pairs are located on the same chromosome. Fifty-three out of these 74 genes are annotated in the Gene Ontology (GO) (and thus in FunSimMat) with BP and MF scores. Figure 3 shows that pairs of genes on the same chromosome showing strongly correlated methylation levels have a typical genomic distance between 1 . e4 and 1 . e6 base pairs. These values are similar to the average distance between neighboring genes of 1.4 . e5 bp that is obtained when assuming that the 2.2 . e4 human genes are evenly spread over the 3 . e9 bases of the genome. However, the plot shows that the co-methylation level is only weakly anti-correlated with genomic distance (r ¼ 20.29). For comparison, Li et al. (21) found that in human peripheral blood mononuclear cells, the co-methylation of CpG sites deteriorated over distance and became nearly undetectable at distances .1000 bp. We did not detect a difference between functionally similar and dissimilar gene pairs.
Relating co-methylation to co-expression
An important point is whether genes showing similar changes of their methylation patterns also show corresponding changes of their expression patterns. We analyzed this by computing co-expression values for the 187 highly co-methylated gene pairs. The mean Pearson correlation coefficient for these gene pairs was quite low (r mean ¼ 0.136). Only the pairs CD48 and SLAMF1, as well as SPRR1B and SPRR2D, showed values .0.75 (r ¼ 0.851 and 0.783, respectively). Eleven pairs showed co-expression r . 0.5. Out of these, 10 pairs are located on the same chromosome, and the 6 pairs with functional annotation available have high to very 
Functional similarity
After filtering co-methylated genes, all gene pairs were ordered according to the level of co-methylation observed. Table 1 shows the 10 gene pairs showing the highest correlations. Interestingly, half of the cases involved two genes from the same gene family: SPRR1B and SPRR1A; FCN2 and FCN1; SPRR1B and SPRR4; REG1B and REG1P; SPRR3 and SPRR4, respectively. Next, we computed the functional similarity between the same 187 pairs of strongly co-methylated genes having unique UniProt identifiers (Supplementary Material, Table S1 ). Among these, 74 pairs involved genes located on the same chromosome and 113 involved genes on different chromosomes. Out of these, 28 and 70 pairs had complete GO annotations (Fig. 4) . The analysis showed that in breast cancer samples, co-methylated gene pairs on the same chromosome share a higher combined functional similarity (BP, MF, CC) than average pairs between the 133 candidate genes and the 9889 genes, annotated in the Biomyn database out of the 14 475 genes on the Illumina27k Chip (P-value same_chr ¼ 3.1 . e 2 4, Welch's two-tailed t-test).
In the same fashion, we also analyzed the functional similarity of the 133 candidate genes to the 22 genes associated with breast cancer in OMIM (Supplementary Material,  Fig. S4 ). Whereas some of the candidate genes (e.g. TOX2 and GCM2) showing a large functional similarity to the 22 known OMIM genes of more than 0.8 have already been investigated in the context of breast cancer (22, 23) , the 133 candidate genes as a group are less similar to the 22 OMIM genes than all 9889 genes on the Illumina27k chip containing functional annotations (P-value ¼ 4.55 . e -4, Welch onetailed t-test). This suggests that co-methylation analysis identifies different gene players of the cellular network that are related to breast cancer on top of the 22 well-known breast cancer genes listed in OMIM.
For comparison, we also performed co-methylation analysis of the OMIM breast cancer genes (19 out of 22) that are included in the TCGA data samples. None of them passed our strict three-stage filtering. This is largely due to the fact that most of these genes tend to be unmethylated throughout all samples (Supplementary Material, Fig. S2 ). If we leave out the last filtering condition, only the BARD1 gene remains, showing a maximum correlation value of r ¼ 0.626.
Enriched pathways
Besides analyzing the co-methylation of pairs of genes, one may also want to identify larger groups of genes that show similar methylation levels and investigate whether these genes belong to common cellular pathways. Clustering the methylation profiles by the affinity propagation algorithm yielded 29 clusters of genes with similar methylation patterns. We then used the tool DAVID to search in individual clusters for enriched KEGG pathways and enriched diseases, respectively (Supplementary Material, Tables S2 and S3 ). This resulted in four KEGG pathways that were significantly enriched with EASE score P-values , 0.01 in individual co-methylation clusters (maturity onset diabetes of the young, hematopoietic cell lineage, long-term depression and ECM -receptor interaction).
DISCUSSION
Although DNA methylation of gene promoters is commonly viewed to be associated with gene silencing by altering the interaction of DNA with transcription factors and by affecting chromatin organization, promoter-associated DNA methylation and gene expression differences seem in fact to be only modestly correlated (24) . For example, Feinberg and colleagues (25) reported a slightly negative correlation of 20.27 between differentially methylated regions within 2 kb of the gene's transcription start site and expression in cancer and healthy colon samples. Bock and co-workers (26) reported Figure 4 . Q-Q plot comparing the distributions of two sets of rfunSimAll scores. Shown on the x-axis are the scores for the functional similarity among the 98 most strongly co-methylated and fully annotated pairs of genes. Here, we distinguished between gene pairs on the same chromosome and on different chromosomes. Shown on the y-axis are the scores for the functional similarity of gene pairs formed between the 133 candidate genes and the 9889 annotated genes found on the HumanMethylation27 chip that could be successfully mapped to BioMyn. The semantic similarities have values between 0 (not similar at all) and 1 (totally similar) and are based on the distance of the GO terms to the lowest common ancestor in the GO hierarchy and the specificity of the lowest common ancestor.
an even lower correlation of DNA methylation and gene expression during in vivo differentiation of blood and skin stem cells (20.15 to 20.25) . The effects of methylation in other genetic regions on the levels of gene expression are even less well understood. Here, we found a low positive correlation of the expression values of highly co-methylated gene pairs (0.136). Since our analysis focused on the relatively small number of highly co-methylated gene pairs, these values certainly fall in the range of values observed in the previous studies. Notably, those gene pairs showing high levels of co-methylation as well as co-expression are very often located on the same chromosome and often have highly similar functions.
As mentioned before, clustering of the methylation data resulted in four KEGG pathways that were significantly enriched with EASE score P-values , 0.01 in individual co-methylation clusters (maturity onset diabetes of the young, hematopoietic cell lineage, long-term depression and ECM -receptor interaction). Interestingly, genes belonging to three out of four of these enriched pathways were previously shown to be associated with breast cancer. For example, KEGG pathway 'hsa04950' is related to a form of type II diabetes termed maturity onset diabetes of the young. It involves the gene NEUROD1, which is a chemosensitivity marker in estrogen receptor-negative breast cancer (27) . Second, two members of the CD1 gene family, which are participants of the hematopoietic cell linage pathway, are already pharmaceutically valid targets of breast cancer research (28) . Moreover, CD1A was suggested as a prognostic marker for breast cancer (29) . Finally, ECM -receptor interaction was also suggested to play an important role in carcinogenesis (30) .
In conclusion, we have shown that unexpectedly highly correlated DNA methylation levels are found in gene pairs from breast cancer samples. Importantly, correlated gene pairs show strong, combined functional similarity. These findings may be helpful to annotate unknown genes and to suggest candidate genes that should be closely investigated with respect to a particular disease. We believe that our findings may also be transferable to other types of cancer, and possibly to related diseases.
MATERIALS AND METHODS
Tumor data
DNA methylation data for tissue samples from breast invasive carcinoma patients were obtained from The Cancer Genome Atlas (TCGA) Data Portal. The level-three DNA methylation data used here were deposited by the group of Dr Peter Laird of Johns Hopkins and the University of Southern California and consist of preprocessed DNA methylation data that were obtained using Illumina's Infinium Human DNA Methylation 27 platform. This BeadChip detects 27 578 CpG Sites in 14 475 RefSeq Genes, among which are 982 cancer-related targets. Since the data are deposited continuously, we first analyzed 183 tumor samples available by September 2011 and later an additional 134 tumor samples as well as 27 matched tissue mostly from adjacent health tissues (Supplementary Material) that were both deposited in October 2011.
Preprocessing of raw data
Every sample is represented by a separate text file that contains the barcode of the samples, the b-value between 0 and 1 (ratio of methylated to the sum of methylated and unmethylated sites), gene symbol, chromosome and gene position. Using Microsoft SQL Server 2008 Express, all 344 samples were downloaded to two tables of our database and parsed. Seventy-three genes that contained NA b-values or did not contain gene symbols were removed. If there were several entries for the same gene within a single sample, the average b-value was computed and assigned to that gene so that every gene had only one respective b-value. Thereby, the number of entries for each sample decreased from about 27 500 to 13 313.
Comparison against randomized data
In order to characterize the statistical significance of the correlations of gene methylation, we repeated the same steps with random data. For this, we generated a random permutation on a per gene level of the original data, using the 'sample' function in R so that the distribution of the b-values in the randomly permutated data is identical to the distribution of b-values in the actual data. The algorithm works as follows: all b-values are selected for the specific gene among all samples. As a result, we have 344 entries for one gene which are then randomly permutated by the 'sample' function. Afterwards, permutated b-values are assigned back to random samples that are most different to the original samples. In effect, this changes their order of appearance during the computation of correlations. This procedure was repeated for all 13 313 genes.
Data filtering
The group of Dr Peter Laird kindly made available to us a list of 2676 unsuitable probes that they had identified in the deposited raw Illumina27k data, which were apparently affected by batch effects. Thus, in the first filtering stage, we excluded any pair of genes showing correlated methylation in the combined cancer and control samples if at least one of the two genes was part of this list of bad probes (Supplementary Material, Fig.  S1A ). To avoid cases where significant correlation is found due to single very high or very low b-values as it is the case for the genes CLK1 and YPF5 (Supplementary Material, Fig.  S1B ), only those genes were kept after stage-two filtering that have no outlier b-values according to the 'boxplot.stats' function in R. The third stage of filtering aimed at removing genes with very small variance of the b-values like in the case of the two genes C1R and LEMD3 (Supplementary Material, Fig. 1C ). For this, we requested that the third and first quartiles of all b-values for a single gene differed by .0.1.
Relating co-methylation with co-expression
A total of 599 gene expression samples were downloaded from the TCGA portal and matched to DNA methylation samples by using barcodes. Altogether, 336 samples were successfully 
Functional similarity
Finally, we characterized the functional similarity of pairs of genes showing highly correlated methylation levels. For this, we computed the functional similarity with respect to the biological process (BPscore), molecular function (MFscore) and cellular component (CCscore) categories (31) of the GO. The functional similarity (1) was computed on the basis of the simRel and GOscore measures (32) (33) (34) funSimAll( p, q) = 
by mapping gene names to UniProt accession identifiers available from the portal www.biomyn.de.
Pathway enrichment analysis
Enriched pathways were identified by affinity propagation clustering, which was performed by the 'apcluster' function in R, using default parameters. Prior to clustering, our threestage filtering was applied to the methylation data of all 13 313 genes. Among the 779 genes that passed the filtering steps, affinity propagation then identified 29 clusters of genes with similar methylation patterns. The members of each cluster were further analyzed for pathway and disease enrichment using the NIH tool DAVID (35) . DAVID uses the so-called EASE score, which is a modified (jackknifed) Fisher's exact P-value, to assess the significance of the results. A P-value , 0.01 and a false discovery rate , 6.3% were chosen as significance thresholds upon filtering the pathway data.
